Inventor · disambiguated record
John Li
Also filed as: LI JOHN · LI JOHN YUEHUA
7 granted patents·7 pending applications·47 citations·filing 1994–2023
80Inventor score
Files withSALUBRIS BIOTHERAPEUTICS INC5SALUBRIS CHENGDU BIOTECH CO LTD2DANA FARBER CANCER INST INC1HARLAN JOHN M1HOB BIOTECH GROUP CORP LTD1
Top patents by PatentIndex Score
14 records- 0184US10160812B2Bispecific HER2 antibodiesMEDIMMUNE LLC·Filed 2015·Granted Dec 25, 2018·4 cites·18 claims
- 0272US5654195AVectors expressing hybrid viruses, methods of use and novel assaysDANA FARBER CANCER INST INC·Filed 1994·Granted Aug 5, 1997·39 cites·19 claims
- 0371US11046741B2Human neuregulin-1 (NRG-1) recombinant fusion protein compositions and methods of use thereofSALUBRIS BIOTHERAPEUTICS INC·Filed 2019·Granted Jun 29, 2021·1 cites·38 claims
- 0468US7964565B2Method of inhibiting inflammation in a mammal by administering Bcl proteinUNIV WASHINGTON CT FOR COMMERCIALIZATION A PUBLIC INSTITUTION OF HIGHER EDUCATION·Filed 2005·Granted Jun 21, 2011·3 cites·10 claims
- 0567US2023322877A1Human neuregulin-1 (nrg-1) recombinant fusion protein compositions and methods of use thereofSALUBRIS BIOTHERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0664US11718652B2Human neuregulin-1 (NRG-1) recombinant fusion protein compositions and methods of use thereofSALUBRIS BIOTHERAPEUTICS INC·Filed 2021·Granted Aug 8, 2023·0 cites·35 claims
- 0757US2025346644A1Novel antibody-cytokine fusion protein, preparation method therefor and use thereofLATTICON SUZHOU BIOPHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 0853US2025228917A1Methods of treating fibrosis and arrhythmia with a neuregulin-1 fusion proteinSALUBRIS BIOTHERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0952US2024254184A1Il-15 fusion proteins and methods of making and using the sameSALUBRIS BIOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1047US2013053329A1Methods of inhibiting apoptosis or inflammation in a mammal by administering an isolated bcl proteinUNIV WASHINGTON·Filed 2012·Application pending·0 cites
- 1144US2020332017A1Antibodies or antigen-binding portions binding cd40 and uses thereofSALUBRIS CHENGDU BIOTECH CO LTD·Filed 2020·Application pending·0 cites
- 1243US8304389B2Methods of inhibiting cell death or inflammation in a mammal by administering a BCL proteinHARLAN JOHN M·Filed 2011·Granted Nov 6, 2012·0 cites·20 claims
- 1342US2021095032A1Antibodies binding pd-1 and uses thereofSALUBRIS CHENGDU BIOTECH CO LTD·Filed 2019·Application pending·0 cites
- 1432US11408895B1Allergen characterization, potent allergen product formulation, comprehensive allergen reagent, and allergy assayHOB BIOTECH GROUP CORP LTD·Filed 2019·Granted Aug 9, 2022·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when John Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →